COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 118 filers reported holding COHERUS BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $174,000 | +1238.5% | 18,108 | +933.0% | 0.01% | – |
| Q2 2022 | $13,000 | -92.3% | 1,753 | -86.6% | 0.00% | -100.0% |
| Q1 2022 | $169,000 | +42.0% | 13,097 | +75.6% | 0.01% | +50.0% |
| Q4 2021 | $119,000 | -51.2% | 7,458 | -57.7% | 0.00% | -50.0% |
| Q2 2021 | $244,000 | +6000.0% | 17,617 | +8752.8% | 0.01% | +700.0% |
| Q3 2019 | $4,000 | -71.4% | 199 | -68.5% | 0.00% | -75.0% |
| Q2 2019 | $14,000 | – | 631 | +4407.1% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 14 | -88.5% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | -85.7% | 122 | -92.6% | 0.00% | -90.9% |
| Q4 2017 | $14,000 | -70.8% | 1,638 | -50.8% | 0.01% | -78.0% |
| Q2 2017 | $48,000 | +242.9% | 3,328 | +586.2% | 0.05% | +257.1% |
| Q4 2016 | $14,000 | -81.3% | 485 | -82.7% | 0.01% | -65.9% |
| Q3 2016 | $75,000 | – | 2,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |